Published in Neurobiol Dis on May 06, 2010
Priorities in Parkinson's disease research. Nat Rev Drug Discov (2011) 1.66
Cerebrospinal fluid biomarkers in Parkinson disease. Nat Rev Neurol (2013) 1.37
Biomarkers of Parkinson's disease: present and future. Metabolism (2014) 1.14
Recent developments in biomarkers in Parkinson disease. Curr Opin Neurol (2013) 1.00
Oxidative stress in genetic mouse models of Parkinson's disease. Oxid Med Cell Longev (2012) 0.98
Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease. Oncotarget (2015) 0.87
The Diagnostic and Differential Diagnosis Utility of Cerebrospinal Fluid α -Synuclein Levels in Parkinson's Disease: A Meta-Analysis. Parkinsons Dis (2015) 0.83
Parkinson's Disease: Assay of Phosphorylated α-Synuclein in Skin Biopsy for Early Diagnosis and Association with Melanoma. Brain Sci (2016) 0.78
Clinical implications from proteomic studies in neurodegenerative diseases: lessons from mitochondrial proteins. Expert Rev Proteomics (2016) 0.75
Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci (2004) 5.55
Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol (2004) 3.79
Do rats have a prefrontal cortex? Behav Brain Res (2003) 3.38
The intralaminar and midline nuclei of the thalamus. Anatomical and functional evidence for participation in processes of arousal and awareness. Brain Res Brain Res Rev (2002) 3.21
The medial prefrontal cortex in the rat: evidence for a dorso-ventral distinction based upon functional and anatomical characteristics. Neurosci Biobehav Rev (2003) 2.87
The application of graph theoretical analysis to complex networks in the brain. Clin Neurophysiol (2007) 2.20
PPIB mutations cause severe osteogenesis imperfecta. Am J Hum Genet (2009) 2.16
Genome-wide association study confirms extant PD risk loci among the Dutch. Eur J Hum Genet (2011) 2.12
Efficacy of community-based physiotherapy networks for patients with Parkinson's disease: a cluster-randomised trial. Lancet Neurol (2009) 2.01
CSF biomarker variability in the Alzheimer's Association quality control program. Alzheimers Dement (2013) 1.90
Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease? Free Radic Biol Med (2008) 1.83
On the beta-binomial model for analysis of spectral count data in label-free tandem mass spectrometry-based proteomics. Bioinformatics (2009) 1.74
The proliferative capacity of the subventricular zone is maintained in the parkinsonian brain. Brain (2011) 1.64
Macrophages and neurodegeneration. Brain Res Brain Res Rev (2005) 1.64
The orbital cortex in rats topographically projects to central parts of the caudate-putamen complex. Neurosci Lett (2007) 1.63
Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status. J Neuroinflammation (2013) 1.59
Disorder-specific neuroanatomical correlates of attentional bias in obsessive-compulsive disorder, panic disorder, and hypochondriasis. Arch Gen Psychiatry (2005) 1.58
Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease. J Alzheimers Dis (2012) 1.57
Proteomics analysis of rat brain postsynaptic density. Implications of the diverse protein functional groups for the integration of synaptic physiology. J Biol Chem (2003) 1.56
Frontal-striatal dysfunction during planning in obsessive-compulsive disorder. Arch Gen Psychiatry (2005) 1.53
The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems. Brain (2008) 1.52
Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus. J Neurol Neurosurg Psychiatry (2013) 1.52
Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease. Neurology (2013) 1.51
Frequency-dependent functional connectivity within resting-state networks: an atlas-based MEG beamformer solution. Neuroimage (2011) 1.47
Interventions for fatigue in Parkinson's disease. Cochrane Database Syst Rev (2015) 1.41
Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints. Alzheimers Dement (2012) 1.31
Lipoic acid affects cellular migration into the central nervous system and stabilizes blood-brain barrier integrity. J Immunol (2006) 1.30
Pneumocephalus by Valsalva's maneuver. Neurology (2003) 1.28
Retracted Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies. Mult Scler Int (2011) 1.26
Direct physiological evidence for synaptic connectivity between medium-sized spiny neurons in rat nucleus accumbens in situ. J Neurophysiol (2003) 1.23
Longterm quiescent cells in the aged human subventricular neurogenic system specifically express GFAP-delta. Aging Cell (2010) 1.22
Frontostriatal system in planning complexity: a parametric functional magnetic resonance version of Tower of London task. Neuroimage (2003) 1.21
Detoxication enzyme inducers modify cytokine production in rat mixed glial cells. J Neuroimmunol (2005) 1.20
Chronic bilateral thalamic stimulation: a new therapeutic approach in intractable Tourette syndrome. Report of three cases. J Neurosurg (2003) 1.16
Subnuclear proteomics in colorectal cancer: identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progression. Mol Cell Proteomics (2010) 1.16
Injury markers predict time to dementia in subjects with MCI and amyloid pathology. Neurology (2012) 1.16
Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan. Gastroenterology (2011) 1.15
Preclinical AD predicts decline in memory and executive functions in subjective complaints. Neurology (2013) 1.15
iTRAQ-based proteomics profiling reveals increased metabolic activity and cellular cross-talk in angiogenic compared with invasive glioblastoma phenotype. Mol Cell Proteomics (2009) 1.14
(Peri)vascular production and action of pro-inflammatory cytokines in brain pathology. Clin Sci (Lond) (2007) 1.14
Early onset Alzheimer's disease is associated with a distinct neuropsychological profile. J Alzheimers Dis (2012) 1.11
Disrupted brain network topology in Parkinson's disease: a longitudinal magnetoencephalography study. Brain (2013) 1.10
The rat prefrontostriatal system analyzed in 3D: evidence for multiple interacting functional units. J Neurosci (2013) 1.10
CSF α-synuclein does not discriminate dementia with Lewy bodies from Alzheimer's disease. J Alzheimers Dis (2010) 1.10
Ultrasound and microbubble-induced intra- and intercellular bioeffects in primary endothelial cells. Ultrasound Med Biol (2009) 1.07
Proteomic profiling of Mycobacterium tuberculosis identifies nutrient-starvation-responsive toxin-antitoxin systems. Mol Cell Proteomics (2013) 1.05
Cognitive decline in Parkinson's disease is associated with slowing of resting-state brain activity: a longitudinal study. Neurobiol Aging (2012) 1.05
Amygdala activity in obsessive-compulsive disorder with contamination fear: a study with oxygen-15 water positron emission tomography. Psychiatry Res (2004) 1.04
Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology. Brain Res Rev (2007) 1.04
Generalized synchronization of MEG recordings in Alzheimer's Disease: evidence for involvement of the gamma band. J Clin Neurophysiol (2002) 1.04
Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications. Clin Biochem (2012) 1.03
In vivo detection of myelin proteins in cervical lymph nodes of MS patients using ultrasound-guided fine-needle aspiration cytology. J Neuroimmunol (2005) 1.02
Molecular tests for colorectal cancer screening. Clin Colorectal Cancer (2011) 1.01
Low-density lipoprotein receptor-knockout mice display impaired spatial memory associated with a decreased synaptic density in the hippocampus. Neurobiol Dis (2004) 0.99
Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson's disease. J Neurol Neurosurg Psychiatry (2009) 0.99
Tissue transglutaminase: a novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases. Eur J Pharmacol (2008) 0.99
Proteomics strategies for target identification and biomarker discovery in cancer. Front Biosci (Landmark Ed) (2009) 0.99
Unravelling the nuclear matrix proteome. J Proteomics (2008) 0.98
CSF neurofilaments in frontotemporal dementia compared with early onset Alzheimer's disease and controls. Dement Geriatr Cogn Disord (2007) 0.97
Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease. Prog Neurobiol (2012) 0.97
Transglutaminases and transglutaminase-catalyzed cross-links colocalize with the pathological lesions in Alzheimer's disease brain. Brain Pathol (2008) 0.96
Microbleeds relate to altered amyloid-β metabolism in Alzheimer's disease. Neurobiol Aging (2011) 0.96
Neurofilament ELISA validation. J Immunol Methods (2009) 0.96
A comparative study of odor identification and odor discrimination deficits in Parkinson's disease. Mov Disord (2008) 0.95
Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42. Biomark Med (2012) 0.95
Influence of variations in sample handling on SELDI-TOF MS serum protein profiles for colorectal cancer. Proteomics Clin Appl (2008) 0.95
Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM. J Proteomics (2012) 0.95
Insulin modulates cocaine-sensitive monoamine transporter function and impulsive behavior. J Neurosci (2011) 0.94
Frontal-striatal abnormalities underlying behaviours in the compulsive-impulsive spectrum. J Neurol Sci (2009) 0.94
Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease. Mov Disord (2013) 0.94
Endogeneous peptide profiling of cerebrospinal fluid by MALDI-TOF mass spectrometry: Optimization of magnetic bead-based peptide capture and analysis of preanalytical variables. Proteomics Clin Appl (2007) 0.93
Three-dimensional organization of dendrites and local axon collaterals of shell and core medium-sized spiny projection neurons of the rat nucleus accumbens. Brain Struct Funct (2008) 0.93
Proteomics of mouse BRCA1-deficient mammary tumors identifies DNA repair proteins with potential diagnostic and prognostic value in human breast cancer. Mol Cell Proteomics (2012) 0.93
Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients. Acta Neuropathol Commun (2014) 0.92
Antioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases. Arch Toxicol (2014) 0.92
Dopaminergic modulation of cortico-cortical functional connectivity in Parkinson's disease: an MEG study. Exp Neurol (2008) 0.91
Comparative protein profiling reveals minichromosome maintenance (MCM) proteins as novel potential tumor markers for meningiomas. J Proteome Res (2010) 0.91
Parkinson's disease-associated parkin colocalizes with Alzheimer's disease and multiple sclerosis brain lesions. Neurobiol Dis (2009) 0.91
Increased resting-state functional connectivity in obese adolescents; a magnetoencephalographic pilot study. PLoS One (2008) 0.91
Predicting dementia in Parkinson disease by combining neurophysiologic and cognitive markers. Neurology (2013) 0.91
Presence of tissue transglutaminase in granular endoplasmic reticulum is characteristic of melanized neurons in Parkinson's disease brain. Brain Pathol (2010) 0.90
Regional differences in gene expression and promoter usage in aged human brains. Neurobiol Aging (2013) 0.90
Hyposmia and executive dysfunction as predictors of future Parkinson's disease: a prospective study. Mov Disord (2009) 0.90
NAD(P)H:quinone oxidoreductase 1 expression in multiple sclerosis lesions. Free Radic Biol Med (2006) 0.90
Neuroinflammation in Parkinson's patients and MPTP-treated mice is not restricted to the nigrostriatal system: microgliosis and differential expression of interleukin-1 receptors in the olfactory bulb. Exp Gerontol (2007) 0.89
The neuroprotective antioxidant alpha-lipoic acid induces detoxication enzymes in cultured astroglial cells. Free Radic Res (2002) 0.89
Biomarker report from the phase II lamotrigine trial in secondary progressive MS - neurofilament as a surrogate of disease progression. PLoS One (2013) 0.89
Intermittent administration of morphine alters protein expression in rat nucleus accumbens. Proteomics (2006) 0.89
Tissue transglutaminase modulates alpha-synuclein oligomerization. Protein Sci (2008) 0.88
A 3D multi-modal and multi-dimensional digital brain model as a framework for data sharing. J Neurosci Methods (2009) 0.88
Patterns of α-synuclein pathology in incidental cases and clinical subtypes of Parkinson's disease. Parkinsonism Relat Disord (2012) 0.88
Classically and alternatively activated bone marrow derived macrophages differ in cytoskeletal functions and migration towards specific CNS cell types. J Neuroinflammation (2011) 0.88
Label-free mass spectrometry-based proteomics for biomarker discovery and validation. Expert Rev Mol Diagn (2012) 0.88
A prediction model to calculate probability of Alzheimer's disease using cerebrospinal fluid biomarkers. Alzheimers Dement (2012) 0.88
Quantification of dopamine transporter binding using [18F]FP-beta-CIT and positron emission tomography. J Cereb Blood Flow Metab (2006) 0.87